Immediate Impact
58 standout
Citing Papers
Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update
2024 Standout
Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies
2024 Standout
Works of Kailin Yu being referenced
Discovery and characterization of a novel irreversible EGFR mutants selective and potent kinase inhibitor CHMFL-EGFR-26 with a distinct binding mode
2017
Discovery of N-(3-(5-((3-acrylamido-4-(morpholine-4-carbonyl)phenyl)amino)-1-methyl-6-oxo-1,6-dihydropyridin-3-yl)-2-methylphenyl)-4-(tert-butyl)benzamide (CHMFL-BTK-01) as a highly selective irreversible Bruton's tyrosine kinase (BTK) inhibitor
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Kailin Yu | 160 | 34 | 31 | 63 | 51 | 18 | 229 | |
| Deepa Bhavsar | 150 | 31 | 17 | 42 | 71 | 13 | 253 | |
| Zongru Jiang | 158 | 26 | 15 | 48 | 37 | 19 | 262 | |
| Michael Burkard | 162 | 88 | 21 | 58 | 59 | 18 | 263 | |
| Lara Ward | 171 | 40 | 13 | 36 | 72 | 14 | 259 | |
| Laura Depta | 183 | 13 | 17 | 41 | 48 | 17 | 228 | |
| Andrew Conroy | 160 | 22 | 46 | 121 | 57 | 11 | 247 | |
| Jayesh Vora | 145 | 17 | 20 | 56 | 42 | 10 | 261 | |
| M W Trader | 101 | 17 | 17 | 77 | 34 | 16 | 217 | |
| Daniel Kukral | 104 | 35 | 23 | 68 | 61 | 9 | 264 | |
| Wenhao Guo | 240 | 14 | 37 | 73 | 43 | 14 | 292 |
All Works
Loading papers...